US Stock MarketDetailed Quotes

TPST Tempest Therapeutics

Watchlist

0.952
+0.094+10.89%

Close Jan 3 16:00 ET

0.960
+0.008+0.80%

Post 19:59 ET

41.54MMarket Cap-0.62P/E (TTM)

Tempest Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-56.96%-10.18M

13.80%-5.51M

13.45%-7.19M

11.96%-27.36M

4.69%-6.18M

28.49%-6.49M

24.03%-6.39M

-16.83%-8.3M

-19.71%-31.07M

18.86%-6.48M

Net income from continuing operations

-55.56%-10.56M

-26.24%-9.57M

-3.51%-7.9M

17.41%-29.49M

17.74%-7.49M

24.15%-6.79M

17.31%-7.58M

10.07%-7.64M

-26.17%-35.71M

-17.02%-9.1M

Depreciation and amortization

10.23%97K

86.75%155K

-29.60%88K

-40.28%381K

-60.83%85K

-56.22%88K

-25.89%83K

15.74%125K

70.59%638K

112.75%217K

Other non cash items

-34.83%305K

-10.28%410K

0.41%487K

20.00%1.88M

5.57%474K

69.57%468K

-2.77%457K

29.33%485K

6.15%1.57M

20.05%449K

Change In working capital

-66.10%-1.36M

940.67%2.18M

31.80%-1.18M

-408.41%-2.68M

-122.42%-343K

21.15%-820K

207.18%209K

-400.70%-1.72M

241.60%868K

259.38%1.53M

-Change in prepaid assets

-202.75%-660K

87.69%747K

-35.71%-38K

-78.91%193K

-96.72%41K

72.16%-218K

47.96%398K

-115.73%-28K

611.17%915K

439.02%1.25M

-Change in payables and accrued expense

-312.35%-334K

4,896.88%1.6M

33.22%-798K

-185.21%-1.24M

-99.12%5K

-171.05%-81K

14.29%32K

-261.05%-1.2M

139.93%1.45M

328.00%570K

-Change in other current liabilities

29.37%-368K

22.62%-171K

32.20%-339K

-8.66%-1.63M

-33.68%-389K

-40.43%-521K

55.08%-221K

-44.09%-500K

-44.33%-1.5M

14.66%-291K

Cash from discontinued investing activities

Operating cash flow

-56.96%-10.18M

13.80%-5.51M

13.45%-7.19M

11.96%-27.36M

4.69%-6.18M

28.49%-6.49M

24.03%-6.39M

-16.83%-8.3M

-19.71%-31.07M

18.86%-6.48M

Investing cash flow

Cash flow from continuing investing activities

-15K

-112.82%-249K

-265.22%-168K

69.75%-170K

98.03%-7K

-23.16%-117K

-1,433.33%-46K

-479.38%-562K

-1,218.52%-356K

Net PPE purchase and sale

---15K

-112.82%-249K

-265.22%-168K

69.75%-170K

98.03%-7K

--0

-23.16%-117K

-1,433.33%-46K

-316.30%-562K

-1,218.52%-356K

Cash from discontinued investing activities

Investing cash flow

---15K

-112.82%-249K

-265.22%-168K

69.75%-170K

98.03%-7K

--0

-23.16%-117K

-1,433.33%-46K

-479.38%-562K

-1,218.52%-356K

Financing cash flow

Cash flow from continuing financing activities

7,238.10%1.54M

283.59%4.56M

922.73%450K

212.22%35.6M

826.81%34.35M

-94.00%21K

-91.74%1.19M

-96.86%44K

-80.69%11.4M

-52,411.11%-4.73M

Net issuance payments of debt

----

--0

----

-131.59%-4.74M

----

Net common stock issuance

17,180.95%3.63M

283.59%4.56M

475.00%253K

301.78%35.6M

286,141.67%34.35M

-94.02%21K

-83.26%1.19M

-96.86%44K

-73.49%8.86M

124.49%12K

Proceeds from stock option exercised by employees

--111K

--0

--197K

--0

6,641.67%7.28M

----

Cash from discontinued financing activities

Financing cash flow

7,238.10%1.54M

283.59%4.56M

922.73%450K

212.22%35.6M

826.81%34.35M

-94.00%21K

-91.74%1.19M

-96.86%44K

-80.69%11.4M

-52,411.11%-4.73M

Net cash flow

Beginning cash position

75.65%31.57M

40.68%32.77M

25.56%39.67M

-39.03%31.6M

-73.34%11.51M

-65.43%17.97M

-49.50%23.29M

-39.03%31.6M

175.39%51.83M

-27.78%43.16M

Current changes in cash

-33.87%-8.66M

77.41%-1.2M

16.87%-6.9M

139.91%8.08M

343.64%28.17M

26.77%-6.47M

-190.69%-5.32M

-45.52%-8.31M

-161.29%-20.23M

-44.13%-11.56M

End cash Position

99.12%22.91M

75.65%31.57M

40.68%32.77M

25.56%39.67M

-73.34%11.51M

-65.43%17.97M

-49.50%23.29M

-39.03%31.6M

Free cash flow

-57.19%-10.2M

11.52%-5.76M

11.92%-7.35M

12.98%-27.53M

9.55%-6.18M

29.34%-6.49M

23.50%-6.51M

-17.43%-8.35M

-21.24%-31.63M

14.69%-6.84M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-56.96%-10.18M	13.80%-5.51M	13.45%-7.19M	11.96%-27.36M	4.69%-6.18M	28.49%-6.49M	24.03%-6.39M	-16.83%-8.3M	-19.71%-31.07M	18.86%-6.48M
Net income from continuing operations	-55.56%-10.56M	-26.24%-9.57M	-3.51%-7.9M	17.41%-29.49M	17.74%-7.49M	24.15%-6.79M	17.31%-7.58M	10.07%-7.64M	-26.17%-35.71M	-17.02%-9.1M
Depreciation and amortization	10.23%97K	86.75%155K	-29.60%88K	-40.28%381K	-60.83%85K	-56.22%88K	-25.89%83K	15.74%125K	70.59%638K	112.75%217K
Other non cash items	-34.83%305K	-10.28%410K	0.41%487K	20.00%1.88M	5.57%474K	69.57%468K	-2.77%457K	29.33%485K	6.15%1.57M	20.05%449K
Change In working capital	-66.10%-1.36M	940.67%2.18M	31.80%-1.18M	-408.41%-2.68M	-122.42%-343K	21.15%-820K	207.18%209K	-400.70%-1.72M	241.60%868K	259.38%1.53M
-Change in prepaid assets	-202.75%-660K	87.69%747K	-35.71%-38K	-78.91%193K	-96.72%41K	72.16%-218K	47.96%398K	-115.73%-28K	611.17%915K	439.02%1.25M
-Change in payables and accrued expense	-312.35%-334K	4,896.88%1.6M	33.22%-798K	-185.21%-1.24M	-99.12%5K	-171.05%-81K	14.29%32K	-261.05%-1.2M	139.93%1.45M	328.00%570K
-Change in other current liabilities	29.37%-368K	22.62%-171K	32.20%-339K	-8.66%-1.63M	-33.68%-389K	-40.43%-521K	55.08%-221K	-44.09%-500K	-44.33%-1.5M	14.66%-291K
Cash from discontinued investing activities
Operating cash flow	-56.96%-10.18M	13.80%-5.51M	13.45%-7.19M	11.96%-27.36M	4.69%-6.18M	28.49%-6.49M	24.03%-6.39M	-16.83%-8.3M	-19.71%-31.07M	18.86%-6.48M
Investing cash flow
Cash flow from continuing investing activities	-15K	-112.82%-249K	-265.22%-168K	69.75%-170K	98.03%-7K	0	-23.16%-117K	-1,433.33%-46K	-479.38%-562K	-1,218.52%-356K
Net PPE purchase and sale	---15K	-112.82%-249K	-265.22%-168K	69.75%-170K	98.03%-7K	--0	-23.16%-117K	-1,433.33%-46K	-316.30%-562K	-1,218.52%-356K
Cash from discontinued investing activities
Investing cash flow	---15K	-112.82%-249K	-265.22%-168K	69.75%-170K	98.03%-7K	--0	-23.16%-117K	-1,433.33%-46K	-479.38%-562K	-1,218.52%-356K
Financing cash flow
Cash flow from continuing financing activities	7,238.10%1.54M	283.59%4.56M	922.73%450K	212.22%35.6M	826.81%34.35M	-94.00%21K	-91.74%1.19M	-96.86%44K	-80.69%11.4M	-52,411.11%-4.73M
Net issuance payments of debt	----	----	----	--0	--0	----	----	----	-131.59%-4.74M	----
Net common stock issuance	17,180.95%3.63M	283.59%4.56M	475.00%253K	301.78%35.6M	286,141.67%34.35M	-94.02%21K	-83.26%1.19M	-96.86%44K	-73.49%8.86M	124.49%12K
Proceeds from stock option exercised by employees	--111K	--0	--197K	--0	--0	--0	--0	--0	6,641.67%7.28M	----
Cash from discontinued financing activities
Financing cash flow	7,238.10%1.54M	283.59%4.56M	922.73%450K	212.22%35.6M	826.81%34.35M	-94.00%21K	-91.74%1.19M	-96.86%44K	-80.69%11.4M	-52,411.11%-4.73M
Net cash flow
Beginning cash position	75.65%31.57M	40.68%32.77M	25.56%39.67M	-39.03%31.6M	-73.34%11.51M	-65.43%17.97M	-49.50%23.29M	-39.03%31.6M	175.39%51.83M	-27.78%43.16M
Current changes in cash	-33.87%-8.66M	77.41%-1.2M	16.87%-6.9M	139.91%8.08M	343.64%28.17M	26.77%-6.47M	-190.69%-5.32M	-45.52%-8.31M	-161.29%-20.23M	-44.13%-11.56M
End cash Position	99.12%22.91M	75.65%31.57M	40.68%32.77M	25.56%39.67M	25.56%39.67M	-73.34%11.51M	-65.43%17.97M	-49.50%23.29M	-39.03%31.6M	-39.03%31.6M
Free cash flow	-57.19%-10.2M	11.52%-5.76M	11.92%-7.35M	12.98%-27.53M	9.55%-6.18M	29.34%-6.49M	23.50%-6.51M	-17.43%-8.35M	-21.24%-31.63M	14.69%-6.84M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--